ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA

Ling, Xiaodong; Zhang, Luquan; Fang, Chengyuan; Liang, Hao; Zhu, Jinhong*; Ma, Jianqun*哈尔滨医科大学
Translational Lung Cancer Research2023-4DOI: 10.21037/tlcr-23-157
1被引8阅读
引用收藏
分享

摘要

Background: Cuproptosis is a novel mitochondrial respiration-dependent cell death mechanism induced by copper that can kill cancer cells via copper carriers in cancer therapy. However, the clinical significance and prognostic value of cuproptosis in lung adenocarcinoma (LUAD) remains unclear. Methods: We performed a comprehensive bioinformatics analysis of the cuproptosis gene set, including copy number aberration, single-nucleotide variation, clinical characteristics, survival analysis, etc. Cuproptosis-related gene set enrichment scores (cuproptosis Z-scores) were calculated in The Cancer Genome Atlas (TCGA)-LUAD cohort using single-sample gene set enrichment analysis (ssGSEA). Modules significantly associated with cuproptosis Z-scores were screened by weighted gene co-expression network analysis (WGCNA). The hub genes of the module were then further screened by survival analysis and least absolute shrinkage and selection operator (LASSO) analysis, in which TCGA-LUAD (497 samples) and GSE72094 (442 samples) were used as the training and validation cohorts, respectively. Finally, we analyzed the tumor characteristics, immune cell infiltration levels, and potential therapeutic agents. Results: Missense mutation and copy number variant (CNV) events were general in the cuproptosis gene set. We identified 32 modules, of which the MEpurple (107 genes) and MEpink (131 genes) modules significantly positively and negatively correlated with cuproptosis Z-scores, respectively. We identified 35 hub genes significantly related to overall survival and constructed a prognostic model consisting of 7 cuproptosisrelated genes in patients with LUAD. Compared with the low-risk group, patients in the high-risk group had a worse overall survival and gene mutation frequency, as well as significantly higher tumor purity. In addition, infiltration of immune cells was also significantly different between the 2 groups. Furthermore, the correlation between the risk scores and half-maximum inhibitory concentration (IC50) of antitumor drugs in the Genomics of Drug Sensitivity in Cancer (GDSC) v. 2 database was explored, revealing differences in drug sensitivity across the 2 risk groups. Conclusions: Our study provided a valid prognostic risk model for LUAD and improved understanding of its heterogeneity, which may aid in the development of personalized treatment strategies.

学科与关键词

关键词
Lung adenocarcinoma (LUAD)prognostic signaturecuproptosisweighted gene co-expression network analysis (WGCNA)tumor immunity
相关
加载中…
  • Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
    Lv, Yanju; Xiao, Yajie; Cui, Xiaoli; Luo, Haitao*; Xu, Long*Frontiers in Genetics, 2022, 13: 1016871.被引 3
  • A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
    Yu, Sheng; Tang, Lingxue; Zhang, Qianqian; Li, Wen; Yao, Senbang; Cai, Yinlian; Cheng, Huaidong*HEREDITAS, 2023, 160(1): 31.被引 2
  • Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
    Kuang, Junjie; Zheng, Zemao; Ma, Wen; Zeng, Shaohui; Wu, Dehua*; Weng, Xie*; Chen, Yuming*Frontiers in Pharmacology, 2023, 14: 1240736.
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Lung Cancer Research
发表日期
2023-04
卷期
第 12 卷, 第 4 期
DOI
10.21037/tlcr-23-157
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82172786]; Haiyan Foundation of Harbin Medical University Cancer Hospital [JJMS2023-04]

作者

  • L

    Ling, Xiaodong (第一作者)

    harbin med univ

  • Z

    Zhang, Luquan

    harbin med univ

查看全部 6 位作者收起作者
  • F

    Fang, Chengyuan

    harbin med univ

  • L

    Liang, Hao

    harbin med univ

  • Z

    Zhu, Jinhong (通讯)

    harbin med univ

  • M

    Ma, Jianqun (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417